Revitalizing Singapore's Alternative Meat Startups After Tough Times

The appeal and financial backing for businesses creating plant-based meats surged during the pandemic but have experienced a decline. Yet, some innovative Singaporean food technology ventures remain optimistic, anticipating that advancements in cell-based and fermentation techniques may reignite interest in this sector.

During the COVID-19 pandemic, factory-produced proteins derived from animals, fungi, and plants became popular as a sustainable food option. Given its limited land resources, Singapore, which relies heavily on imports for food, invested significantly in research and business development in this sector to enhance food security.

"Few regions offer such a diverse cultural blend, ideal for market testing with varied consumer demographics," commented Mihir Pershad, CEO of Umami Bioworks, a local cultivated seafood startup. Unlike plant-based options, cultivated meats are developed in laboratories using animal cells.

Since its inception in 2020, Umami Bioworks has broadened its scope by establishing new branches in both the U.S. and Japan, and it launched in the UK last year. In January, the company revealed its new line of caviar made from sturgeon cells and plant-based materials.

Singapore is set to be one of the first markets to try products from Umami Bioworks, as they await regulatory clearance. This year, they are planning to introduce cultivated unagi, pending successful regulatory protocols.

Singapore gained the distinction of being the first nation to approve lab-grown meat sales in 2020, a move later followed by Israel and the USA. The UK has since approved these innovations for pet food use.

Struggling Industry

Despite notable advancements, the alternative protein sector faces ongoing struggles, largely attributed to elevated costs and limited repeat purchases. The market fell short of the grand expectations set during its initial excitement.

Investment in this industry fell to $1.1 billion in 2024 from $1.5 billion the previous year, based on data from the Good Food Institute.

Challenges are evident as major plans, like Eat Just’s Singapore-based cultivated meat plant, await execution, and some high-end and emerging businesses have halted or downsized operations.

Anli Geng, co-founder of Mycosortia, believes cutting production costs is vital. The company transforms okara, a soybean byproduct, into a protein- and fiber-laden powder. They're looking into solid fermentation methods to reduce reliance on costly equipment.

Mycosortia's innovations such as FibProt have been used to create fish, mayonnaise, and cheese substitutes, and there is keen interest in their quest to produce a cocoa powder alternative.

To break into new markets, some firms are expanding their portfolios to include pharmaceuticals, dyes, and pet food, broadening their utilization of existing ingredients.

Could There Be a Rebound?

Recent fundraising reports suggest optimism. Investment in the Asia-Pacific for innovative foods, including cultured meat and plant-based options, rose by 85% to $204 million in 2024, according to AgFunder.

Nevertheless, securing capital remains a hurdle, with investors worried about sufficient consumer interest, said Pershad. Singapore excels as a testing ground but its limited population challenges its potential as a primary market.

Collaborations with established food companies might increase market reach, but regulatory hurdles for lab-grown meat continue to be an obstacle.

"We had hoped more countries would have established frameworks by now," Pershad noted, highlighting the slow progress in regulatory approvals.

Significant investment from both the public and private sectors is needed to help this industry grow, suggests Mirte Gosker of the Good Food Institute Asia Pacific. Unlike other eco-technologies, alternative proteins lack the substantial government backing seen in renewable energy.

Singapore's role as a leader and partner in innovation is pivotal, as neighboring regions look to its regulation as a model for their systems.